Reduction in doxorubicin toxicity following liposomal delivery

Cancer Treat Rev. 1987 Dec;14(3-4):383-7. doi: 10.1016/0305-7372(87)90034-x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary
  • Colonic Neoplasms / drug therapy
  • Doxorubicin / adverse effects*
  • Doxorubicin / therapeutic use
  • Humans
  • Liposomes / administration & dosage*
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Stomach Neoplasms / drug therapy

Substances

  • Liposomes
  • Doxorubicin